Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in DepressionUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2026-07-27A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.ClinicalTrials.gov · 2026-07-23Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets.Proceedings of the National Academy of Sciences of the United States of America · 2026-06-30Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2026-06-30Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.Proceedings of the National Academy of Sciences of the United States of America · 2026-06-16Therapeutic advances in fibromyalgia: one year in review 2026.Clinical and experimental rheumatology · 2026-06-01Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine functionbioRxiv · 2026-05-180408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart StudySLEEPJ · 2026-05-08Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.Cancer causes & control: CCC · 2026-04-22Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence.Exploratory research in clinical and social pharmacy · 2026-03-01Psychedelic Healing: Adjunct Therapy Harnessing Opened MalleabilityClinicalTrials.gov · 2026-02-13Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".Global advances in integrative medicine and health · 2026-01-01Magic mushrooms and mood: Exploring psilocybin as a depression treatment.JPMA. The Journal of the Pakistan Medical Association · 2026-01-0192. Mushrooms and Mania: Differentiating Psilocybin-Induced Mania From First-Break Bipolar ManiaJournal of the Academy of Consultation-Liaison Psychiatry · 2025-11-01Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.Fundamental & clinical pharmacology · 2025-08-01Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians.Journal of racial and ethnic health disparities · 2025-06-01Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot PhaseClinicalTrials.gov · 2025-05-16Psilocybin in Alcohol Use Disorder With Comorbid DepressionClinicalTrials.gov · 2025-03-19Treatment Expectancies and Psilocybin vs Escitalopram for Depression.JAMA psychiatry · 2025-03-01Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.Psychopharmacology bulletin · 2025-02-03What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?Cochrane Clinical Answers · 2025-01-13Psychedelic Microdosing among Young Adults from Southern California.Journal of psychoactive drugs · 2025-01-01Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyClinicalTrials.gov · 2024-12-04Usage of Psilocybin to Treat Huntington's Disease: A Research ProtocolUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2024-09-05Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research ProtocolUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2024-06-10A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?Psychedelic medicine (New Rochelle, N.Y.) · 2024-06-01Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.Ageing research reviews · 2024-04-01Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental DisordersAnnals of Bioethics & Clinical Applications · 2024-01-01Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.Journal of psychoactive drugs · 2024-01-01Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use.Journal of psychoactive drugs · 2024-01-01Application of psilocybin in mental health disordersTheoretical and Natural Science · 2023-12-20A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic aminesJournal of Biological Chemistry · 2023-09-09Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.Journal of psychiatric practice · 2023-09-01Psilocybin Therapy for Major Depressive Disorder: A Systematic ReviewUndergraduate Research in Natural and Clinical Science and Technology Journal · 2023-07-17Psychedelics reopen the social reward learning critical periodNature · 2023-06-13The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.Experimental and clinical psychopharmacology · 2023-04-01A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01Matrix-assisted laser-desorption/ionization-mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated target plate.Analytical and bioanalytical chemistry · 2023-02-01The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature ReviewUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2023-01-05High time? Psychedelics on cannabis-like fast track to legalizationCanadian Medical Association Journal · 2022-12-17Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.Neuropharmacology · 2022-11-15A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceClinicalTrials.gov · 2022-11-08Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU)ClinicalTrials.gov · 2022-09-22Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a WorkshopNational Academies Press (US), Washington (DC) · 2022-09-01Evaluation of Psilocybin in Anorexia Nervosa: Safety and EfficacyClinicalTrials.gov · 2022-07-25A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01New Paradigms of Old Psychedelics in Schizophrenia.Pharmaceuticals (Basel, Switzerland) · 2022-05-23Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020Journal of Medical and Health Studies · 2021-12-31Policy in focus: Is psilocybin the next cannabis?CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021-11-15Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.Experimental and clinical psychopharmacology · 2021-10-01Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.Proceedings of the National Academy of Sciences of the United States of America · 2021-04-27Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018Research Square · 2020-11-18P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brainEuropean Neuropsychopharmacology · 2020-11-01Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushroomsJournal of Pharmaceutical and Biomedical Analysis · 2020-10-01Psilocybin occasioned mystical-type experiences.Human psychopharmacology · 2020-09-01Dynamic coupling of whole-brain neuronal and neurotransmitter systems.Proceedings of the National Academy of Sciences of the United States of America · 2020-04-28Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings.Proceedings of the National Academy of Sciences of the United States of America · 2020-02-04A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines.Human psychopharmacology · 2020-01-01Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.Experimental and clinical psychopharmacology · 2019-06-01A New Spectrophotometric Method for the Determination of Psilocin and PsilocybinInternational Journal of Analytical and Applied Chemistry · 2017-01-01DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocinJournal of Pharmaceutical and Biomedical Analysis · 2016-06-01Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences of the United States of America · 2016-05-03Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache.CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016-02-16Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake RatsBiological ^|^ Pharmaceutical Bulletin · 2015-01-01Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.Scandinavian journal of clinical and laboratory investigation · 2013-08-01Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.Human psychopharmacology · 2012-07-01Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences of the United States of America · 2012-02-07Iconography in Bradshaw rock art: breaking the circularity.Clinical & experimental optometry · 2011-09-01Patterns of simultaneous polysubstance use in drug using university students.Human psychopharmacology · 2006-06-01Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in manJournal of Pharmaceutical and Biomedical Analysis · 2002-09-01Synthetic Studies of Psilocin Analogs Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.Chemical and Pharmaceutical Bulletin · 2002-01-01Hallucinogenic drugs attenuate the subjective response to alcohol in humans.Human psychopharmacology · 2000-10-01Psilocin, psilocybin, serotonin and urea in Panaeolus cyanescens from various originThe Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center) · 1991-12-31Occurrence of psilocybin, psilocin and baeocystin in Gymnopilus purpuratusThe Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center) · 1988-12-31Absence of psilocybin in species of fungi previously reported to contain psilocybin and related tryptamine derivativesThe Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center) · 1987-12-31Occurrence of Psilocybin and Baeocystin in the genus Inocybe (Fr.) FrThe Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center) · 1984-12-31Extraordinary experiences during cross-modal perception.Perceptual and motor skills · 1976-12-01Biosynthesis of psilocybin. II. Incorporation of labelled tryptamine derivatives.Acta chemica Scandinavica · 1968-01-01Zur Identifizierung von Psilocin, einem psychotropen Inhaltstoff mexikanischer Rauschpilze der Gattungen Psilocybe und StrophariaAnalytical and Bioanalytical Chemistry · 1960-01-01